Form 8-K Edwards Lifesciences For: Jun 03
Edwards Lifesciences Corp false 0001099800 0001099800 2024-06-03 2024-06-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 3, 2024
(Exact name of registrant as specified in its charter)
Delaware 1-15525 ... (continue reading...)
Form 6-K NOMURA HOLDINGS INC For: Jun 03
FORM 6-K
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
Commission File Number: 1-15270
For the month of June 2024
NOMURA HOLDINGS, INC.
(Translation of registrant’s name into English)
13-1, Nihonbashi 1-chome
Chuo-ku, Tokyo 103-8645
Japan
(Address of principal executive offices)
Indicate by check mark whether the registrant... (continue reading...)
Form 6-K ASTRAZENECA PLC For: Jun 03
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For the
month of June 2024
Commission
File Number: 001-11960
AstraZeneca PLC
1
Francis Crick Avenue
Cambridge
Biomedical Campus
Cambridge
CB2 0AA
United
Kingdom
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F... (continue reading...)
Form 6-K INTERCONTINENTAL HOTELS For: Jun 03
SECURITIES
AND EXCHANGE COMMISSION
Washington
DC 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 AND 15d-16
OF
THE
SECURITIES EXCHANGE ACT OF 1934
For 03
June 2024
InterContinental Hotels Group PLC
(Registrant's
name)
1
Windsor Dials, Arthur Road, Windsor, SL4 1RS, United
Kingdom
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file... (continue reading...)
Form SD LUXFER HOLDINGS PLC
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549______________________________________________FORM SDSPECIALIZED DISCLOSURE REPORT______________________________________________LUXFER HOLDINGS PLC ______________________________________________(Name of Registrant as Specified in Charter)England and Wales001-3537098-1024030(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)8989 North Port... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K BECTON DICKINSON & CO For: Jun 03
-
Form F-6/A Jiayin Group Inc. Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary
-
Form 8-K Polar Power, Inc. For: May 30
-
Form DEFA14A Tesla, Inc.
-
Form 6-K Melco Resorts & Entertai For: Jun 03
-
Form 253G2 Emerging Fuels Technolog
-
Form 424B5 Life360, Inc.
-
Form 6-K TAKEDA PHARMACEUTICAL For: Jun 03
-
Form SCHEDULE 13D/A Avinger Inc Filed by: Zylox-Tonbridge Medical Technology Co., Ltd.
-
Form D A.P. Gilfoyle Laminar
-
Form 6-K RYANAIR HOLDINGS PLC For: Jun 03
-
Form D A.P. Gilfoyle Muon Fund
-
Form 6-K PURPLE BIOTECH LTD. For: Jun 03
-
Form 8-K Greenwave Technology For: May 29
-
Form 6-K INDIVIOR PLC For: Jun 03
-
Form ARS Safe & Green Development For: Dec 31
-
Form 8-K Summit Therapeutics Inc. For: Jun 03
-
Form 6-K Gogoro Inc. For: Jun 03
-
Form N-23C3A Franklin BSP Private For: Jun 03
-
Form SD/A AngloGold Ashanti PLC
-
Form 144 CHECK POINT SOFTWARE Filed by: Spokoiny Alex
-
Form 6-K TOYOTA MOTOR CORP/ For: Jun 03
-
Form 8-K Greenwave Technology For: May 29
-
Form 3 Greenpro Capital Corp. For: Jun 01 Filed by: Chee Wah Chew
-
Form 8-K Greenpro Capital Corp. For: May 31
-
Form 6-K WOODSIDE ENERGY GROUP For: Jun 03
-
Form 6-K HUTCHMED (China) Ltd For: Jun 03
-
Form D/A CW Natural Resources
-
Form 6-K GSK plc For: Jun 03
-
Form 8-K Chemours Co For: May 31
-
Form 6-K Tencent Music Entertainm For: Jun 03
-
Form S-1/A Rapport Therapeutics,
-
Form 6-K INDIVIOR PLC For: Jun 03
-
Form 6-K Burning Rock Biotech For: Jun 03
-
Form 6-K KE Holdings Inc. For: Jun 03
-
Form 6-K SUMITOMO MITSUI FINANCIA For: Jun 03
-
Form 6-K The9 LTD For: Jun 03
-
Form F-1/A Novelis Inc.
-
Form 8-K/A Sharps Technology Inc. For: May 30
-
Form 425 Summit Midstream Partner Filed by: Summit Midstream Partners, LP
-
Form 6-K DR REDDYS LABORATORIES For: Jun 02
-
Form 15-12G Landos Biopharma, Inc.
-
Form F-1/A Mercurity Fintech Holdin
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form EFFECT Context Therapeutics
-
Form 497 Innovator ETFs Trust
-
Form EFFECT SAFE & GREEN HOLDINGS
-
Form EFFECT CREDIT SUISSE AG
